Literature DB >> 23359166

Pooled shRNA screenings: experimental approach.

Ruth Rodriguez-Barrueco1, Netonia Marshall, Jose M Silva.   

Abstract

RNA interference (RNAi) has emerged as a powerful genetic strategy to functionally interrogate the entire genome by loss-of-function studies. In the last years, several arrayed shRNA libraries that can silence almost all the human genome have been developed. The generation of new and more efficient shRNA plasmids has allowed performing genetic screens in a pooled fashion and provides the opportunity to investigate the entire genome finding relevant genes to any biological process. In this chapter, the pipeline and methods to perform a pooled shRNA screen are discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23359166     DOI: 10.1007/978-1-62703-287-2_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  An Inhibitor of PIDDosome Formation.

Authors:  Ruth Thompson; Richa B Shah; Peter H Liu; Yogesh K Gupta; Kiyohiro Ando; Aneel K Aggarwal; Samuel Sidi
Journal:  Mol Cell       Date:  2015-04-30       Impact factor: 17.970

2.  Different STAT Transcription Complexes Drive Early and Delayed Responses to Type I IFNs.

Authors:  Ali A Abdul-Sater; Andrea Majoros; Courtney R Plumlee; Stuart Perry; Ai Di Gu; Carolyn Lee; Sujan Shresta; Thomas Decker; Christian Schindler
Journal:  J Immunol       Date:  2015-05-27       Impact factor: 5.422

Review 3.  Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference.

Authors:  Rodolphe Barrangou; Amanda Birmingham; Stefan Wiemann; Roderick L Beijersbergen; Veit Hornung; Anja van Brabant Smith
Journal:  Nucleic Acids Res       Date:  2015-03-23       Impact factor: 16.971

4.  MYC is a critical target of FBXW7.

Authors:  Mai Sato; Ruth Rodriguez-Barrueco; Jiyang Yu; Catherine Do; Jose M Silva; Jean Gautier
Journal:  Oncotarget       Date:  2015-02-20

5.  Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells.

Authors:  Haiying Cheng; Zhenfeng Zhang; Ruth Rodriguez-Barrueco; Alain Borczuk; Huijie Liu; Jiyang Yu; Jose M Silva; Simon K Cheng; Roman Perez-Soler; Balazs Halmos
Journal:  Oncotarget       Date:  2016-05-17

6.  Measuring sequencer size bias using REcount: a novel method for highly accurate Illumina sequencing-based quantification.

Authors:  Daryl M Gohl; Alessandro Magli; John Garbe; Aaron Becker; Darrell M Johnson; Shea Anderson; Benjamin Auch; Bradley Billstein; Elyse Froehling; Shana L McDevitt; Kenneth B Beckman
Journal:  Genome Biol       Date:  2019-04-29       Impact factor: 13.583

7.  Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-/HER2+ breast cancers.

Authors:  Ruth Rodriguez-Barrueco; Jiyang Yu; Laura P Saucedo-Cuevas; Mireia Olivan; David Llobet-Navas; Preeti Putcha; Veronica Castro; Eva M Murga-Penas; Ana Collazo-Lorduy; Mireia Castillo-Martin; Mariano Alvarez; Carlos Cordon-Cardo; Kevin Kalinsky; Matthew Maurer; Andrea Califano; Jose M Silva
Journal:  Genes Dev       Date:  2015-07-30       Impact factor: 11.361

8.  Host-directed antimicrobial drugs with broad-spectrum efficacy against intracellular bacterial pathogens.

Authors:  Daniel M Czyż; Lakshmi-Prasad Potluri; Neeta Jain-Gupta; Sean P Riley; Juan J Martinez; Theodore L Steck; Sean Crosson; Howard A Shuman; Joëlle E Gabay
Journal:  MBio       Date:  2014-07-29       Impact factor: 7.867

9.  HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers.

Authors:  Preeti Putcha; Jiyang Yu; Ruth Rodriguez-Barrueco; Laura Saucedo-Cuevas; Patricia Villagrasa; Eva Murga-Penas; Steven N Quayle; Min Yang; Veronica Castro; David Llobet-Navas; Daniel Birnbaum; Pascal Finetti; Wendy A Woodward; François Bertucci; Mary L Alpaugh; Andrea Califano; Jose Silva
Journal:  Breast Cancer Res       Date:  2015-12-08       Impact factor: 6.466

10.  SEC14L2 enables pan-genotype HCV replication in cell culture.

Authors:  Mohsan Saeed; Ursula Andreo; Hyo-Young Chung; Christine Espiritu; Andrea D Branch; Jose M Silva; Charles M Rice
Journal:  Nature       Date:  2015-08-12       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.